Study of Sargramostim in Patients With COVID-19

Conditions:   COVID-19;   Sars-CoV2 Interventions:   Drug: Sargramostim;   Drug: Standard of care Sponsor:   Partner Therapeutics, Inc. Not yet recruiting

Source: ClinicalTrials.gov - June 2, 2020 Category: Research Source Type: clinical trials